BREAKING NEWS
Cloud Server Hosting For Online Businesses
Inexpensive SEO Services
Benefits of Wanting to play Free Online Slot machines
Medroxalol

Summary

Medroxalol is a vasodilator beta blocker also classified as a mixed receptor blocker as it blocks both alpha and beta receptors.[1]

Medroxalol
Identifiers
  • 5-(2-{[4-(1,3-Benzodioxol-5-yl)-2-butanyl]amino}-1-hydroxyethyl)-2-hydroxybenzamide
CAS Number
  • 56290-94-9
PubChem CID
  • 41835
ChemSpider
  • 38173
UNII
  • 7PX96289JA
CompTox Dashboard (EPA)
  • DTXSID30866550 Edit this at Wikidata
ECHA InfoCard100.054.618 Edit this at Wikidata
Chemical and physical data
FormulaC20H24N2O5
Molar mass372.421 g·mol−1
3D model (JSmol)
  • Interactive image
  • O=C(N)c1cc(ccc1O)C(O)CNC(C)CCc2ccc3OCOc3c2
  • InChI=1S/C20H24N2O5/c1-12(2-3-13-4-7-18-19(8-13)27-11-26-18)22-10-17(24)14-5-6-16(23)15(9-14)20(21)25/h4-9,12,17,22-24H,2-3,10-11H2,1H3,(H2,21,25)
  • Key:MPQWSYJGFLADEW-UHFFFAOYSA-N

Synthesis edit

 
Medroxalol synthesis:[2]

For the first step, salicylamide (1) is the subject of a Friedel-Crafts acetylation and then the aromatic methylketone is halogenated. in the usual manner. The bromide in 2 is then displaced by the nitrogen in N-benzyl-1-(3',4'-methylenedioxyphenyl)-3-butylamine (3), which is itself prepared by reductive amination on the corresponding ketone. The product of the last step (4) is catalytically hydrogenated. This serves the dual purpose both of reducing the ketone and removing the benzyl protecting group affording the product medroxalol (5). Note that a benzyl protecting group is not necessarily used.

See also edit

References edit

  1. ^ Dage RC, Cheng HC, Woodward JK (1981). "Cardiovascular properties of medroxalol, a new antihypertensive drug". Journal of Cardiovascular Pharmacology. 3 (2): 299–315. doi:10.1097/00005344-198103000-00009. PMID 6166802.
  2. ^ J. T. Suh and T. M. Bare, U.S. patent 3,883,560; Chem.Abstr. 83, 78914J (1975).